Topic: infectious disease
By employing heart rate signals, physical activity and sleep quality, common Fitbit trackers may be able to predict the spread of the flu.
Two years after hiving off its healthcare assets into a subsidiary, Intrexon is bringing those assets back into the fold.
Roche is launching its in vitro diagnostic test for the Zika virus in countries accepting the CE mark, intended to help screen blood supplies.
VBI's Sci-B-Vac protected twice as many people than GSK's Engerix-B did after the second dose.
Protection against active pulmonary tuberculosis disease remained up around 50%, suggesting the candidate provides lasting immunity.
The goal is to start testing in vivo gene-based treatments for the diseases in humans within 10 years.
Researchers are studying the retrovirus KoRV-A, which is spreading among koalas, to gain new insights into how DNA evolves.
The FDA approved its first rapid in vitro diagnostic for confirming Ebola virus infections with potential results in about a half-hour.
Micro cap anti-infective biotech Aridis Pharmaceuticals has gained a new chief medical officer in the form of former Takeda Vaccines exec Paul Mendelm
The deal gives Merck the chance to pick up three assets against undisclosed diseases in return for up to $347.5 million per projects in milestones.